Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

226

Participants

Timeline

Start Date

May 1, 2026

Primary Completion Date

May 1, 2028

Study Completion Date

July 1, 2028

Conditions

Sickle-Cell Disease with Crisis

Interventions

DRUG

Parecoxib

Single dose of 40mg of IV Parecoxib.

DRUG

Morphine

Single dose of 5 mg of IV Morphine.

All Listed Sponsors

collaborator

Armed Forces Hospital, Oman

UNKNOWN

lead

Oman Medical Speciality Board

OTHER_GOV